A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer

Patricia LoRusso, Erika Hamilton, Cynthia Ma, Neelima Vidula, Rebecca G. Bagley, Steven Troy, Miriam Annett, Ziyang Yu, Maureen G. Conlan, Amy Weise

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences